VMP 39694611000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Cefuroxime 250mg tablets
BNF code 0501021K0AAABAB
Virtual Therapeutic Moiety Cefuroxime
Date identifier became valid 26 May 2021
Previous product identifier 323869005
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Cefuroxime axetil
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372833007
Strength value numerator 250.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Cefuroxime 250mg tablets (A A H Pharmaceuticals Ltd)
Cefuroxime 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Cefuroxime 250mg tablets (CST Pharma Ltd)
Cefuroxime 250mg tablets (Medihealth (Northern) Ltd)
Cefuroxime 250mg tablets (Phoenix Healthcare Distribution Ltd)
Cefuroxime 250mg tablets (Sandoz Ltd)
Cefuroxime 250mg tablets (Sigma Pharmaceuticals Plc)
Zinnat 250mg tablets (CST Pharma Ltd)
Zinnat 250mg tablets (Sandoz Ltd)
Zinnat 250mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Cefuroxime 250mg tablets 12 tablet
Cefuroxime 250mg tablets 14 tablet
Cefuroxime 250mg tablets 50 tablet
Cefuroxime 250mg tablets 8 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback